Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Irilliant Announces New Patent

Abstract:
Broad Claims Granted for Aerosol Synthesis of Nanomaterials

Irilliant Announces New Patent

Mountainview, CA | Posted on July 12th, 2010

Irilliant, Inc., a developer of high-throughput manufacturing processes for nanomaterials, has further enhanced and protected its CAFS (Chemical Aerosol-Flow Synthesis) process with a soon-to-be-issued U.S. patent.

The patent, "Controlled synthesis of nanoparticles using continuous liquid-flow aerosol method," will include claims for large-scale production of high-quality nanoparticles from aerosol. Earlier patented processes were not suitable for large-scale production, nor did they result in products of equally high quality.

In Irilliant's CAFS process, liquid containing the precursors for the synthesis flows continuously through a sprayer, which in turn generates micron-sized droplets. These droplets serve as microreactors, and facilitate the creation of narrow-size distributed nanoparticles. Spraying large amounts of liquid in the reactor, facilitates manufacture of high-quality, surface-stabilized nanoparticles in large quantities. Ultrasonic or large scale industrial sprayers can be used to further enhance throughput. This configuration permits production of a higher quality product with a greater yield compared to previous methods.

Nanomaterials are used in a variety of emerging technologies including next generation photovoltaics, electronic displays, and lighting. "To sustain the explosive growth in these arenas, reliable, high volume production of nanomaterials at the proper pricing points will be needed," said Stephanos Papademetriou, Irilliant's President and CEO. "This addition to our IP portfolio gives us a tremendous competitive advantage. It also moves us closer to our goal of becoming a global leader in the production of a diverse array of quality nanomaterials at price points that are orders of magnitude lower than any other method of nanomaterial synthesis."

####

About Irilliant
Irilliant, Inc. is a leading nanosynthesis manufacturing company. By utilizing the company's patented CAFS technology, Irilliant can manufacture large quantities of a variety of nearly monodisperse colloidal solutions of nanomaterials (including CdSe, CdTe, CdSe/ZnS, CdS Quantum Dots, nanometals, and nano-oxides) at extraordinarily low cost.

The company specializes in post processing of nanomaterials for further functionalization and adaptation into intelligent devices. Areas of expertise include modification of polymers with nanosilver for enhanced antimicrobial activity, fluorescently encoded and magnetically enhanced microparticles, high-density binary code fluorescent markers, ultra-high magnetization superparamagnetic nanomagnets, and quantum dot fiber structures.

For additional information, please visit www.Irilliant.com

For more information, please click here

Contacts:
Irilliant, Inc.
Marketing Department
67 East Evelyn Avenue
Suite 5
Mountain View, CA 94041
Email Contact
Tel: (650) 575-4450

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

New class of protein misfolding simulated in high definition: Evidence for recently identified and long-lasting type of protein misfolding bolstered by atomic-scale simulations and new experiments August 8th, 2025

Sensors innovations for smart lithium-based batteries: advancements, opportunities, and potential challenges August 8th, 2025

Deciphering local microstrain-induced optimization of asymmetric Fe single atomic sites for efficient oxygen reduction August 8th, 2025

Lab to industry: InSe wafer-scale breakthrough for future electronics August 8th, 2025

Materials/Metamaterials/Magnetoresistance

First real-time observation of two-dimensional melting process: Researchers at Mainz University unveil new insights into magnetic vortex structures August 8th, 2025

Researchers unveil a groundbreaking clay-based solution to capture carbon dioxide and combat climate change June 6th, 2025

A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025

Institute for Nanoscience hosts annual proposal planning meeting May 16th, 2025

Announcements

Sensors innovations for smart lithium-based batteries: advancements, opportunities, and potential challenges August 8th, 2025

Deciphering local microstrain-induced optimization of asymmetric Fe single atomic sites for efficient oxygen reduction August 8th, 2025

Japan launches fully domestically produced quantum computer: Expo visitors to experience quantum computing firsthand August 8th, 2025

ICFO researchers overcome long-standing bottleneck in single photon detection with twisted 2D materials August 8th, 2025

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project